Fidia Issues 4 Million New Shares After Latest Convertible Bond Conversion

An announcement from Fidia Spa ( (IT:FDA) ) is now available.

Fidia has confirmed a further step in the execution of its 2026 convertible bond programme reserved for Global Growth Holding Limited, with the conversion of four bonds from the sixth tranche at a price of €0.01 per share. The operation resulted in the issuance of 4,000,000 new shares that are immediately admitted to trading, supporting liquidity in the stock and gradually reinforcing the company’s equity structure.

Following this conversion, the portion of the convertible loan subscribed has reached a nominal €1.5 million, with €1.29 million of the related capital increase already underwritten and 21 bonds of the sixth tranche still to be converted. Share capital rises by €40,000 to €11,137,761.90, bringing the total number of shares to 88,542,927, a development that further dilutes existing shareholders but provides additional financial resources to back Fidia’s growth trajectory in its specialised industrial markets.

More about Fidia Spa

Fidia S.p.A., based in Turin and listed on Euronext Milan, is a leading provider of numerical control technology and high-performance integrated milling systems. The group focuses on complex-shape milling solutions for the automotive mould sector and the aerospace industry, supplying numerical controls, high-speed milling machines and CAM software worldwide.

With more than 50 years of experience and about 135 employees, Fidia is among the few industrial players able to cover the entire milling process, from programming to the finished product. Its integrated offer and global support network underpin its positioning in niche, high-precision manufacturing markets where technological reliability and process integration are critical.

Average Trading Volume: 2,374,058

Technical Sentiment Signal: Strong Sell

Current Market Cap: €785.1K

See more data about FDA stock on TipRanks’ Stock Analysis page.